| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |